The Cellular Health Screening Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Cellular Health Screening Market:
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
According to The Business Research Company’s Cellular Health Screening Global Market Report 2024, The cellular health screening market size has grown rapidly in recent years. It will grow from $3.01 billion in 2023 to $3.37 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing health consciousness, aging population, preventive healthcare trends, rising chronic diseases, advancements in biomarker research.
The cellular health screening market size is expected to see rapid growth in the next few years. It will grow to $5.04 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to personalized medicine emphasis, corporate wellness programs, government initiatives for preventive healthcare, rising lifestyle-related health issues. Major trends in the forecast period include ai and machine learning applications, increasing consumer awareness, integration with wearable devices, collaborations for research and development, regulatory support and standardization.
The rise in chronic diseases is expected to propel the growth of the cellular health screening market going forward. Chronic diseases are medical problems that last for a long time and necessitate continuing management and care. Cellular health screening can help prevent disease or reduce the severity of illness by detecting people who have chronic diseases due to factors such as genetic predisposition, lifestyle choices, environmental conditions, and underlying health issues. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based intergovernmental organization, the most common type of heart disease was coronary heart disease, which affected around 20.1 million people aged 20 and older. Every 40 seconds, someone suffers from a heart attack, and nearly 805,000 people in the United States experience a heart attack each year. Furthermore, in January 2023, according to the National Library of Medicine, a US-based biomedical library operated by the federal government, the number of people in the USA aged 50 and older who have at least one chronic condition is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Therefore, the rise in chronic diseases is driving the growth of the cellular health screening market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10561&type=smp
The cellular health screening market covered in this report is segmented –
1) By Test Type: Single Test Panels, Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests, Multi-test Panels
2) By Sample Type: Blood, Saliva, Serum, Urine
3) By Collection Site: Home, Office, Hospital, Diagnostic Labs
Major companies operating in the cellular health screening market focused on developing innovative solutions such as lung cancer screening through a routine blood test. Lung cancer screening refers to the use of specific medical tests and procedures to detect lung cancer in individuals who may not be experiencing symptoms but are at a higher risk of developing the disease. For instance, in October 2023, DELFI Diagnostics, Inc., a US-based company developing next-generation blood-based tests announced the launch of the ‘FirstLook Lung’. FirstLook is a blood test providing a convenient, precise, and personalized outcome by assessing the probability of detecting lung cancer using low-dose CT (LDCT), achieving a negative predictive value (NPV) of 99.7 percent. It delivers precise outcomes and provides clear data, aiding both patients and healthcare providers in identifying the optimal course of action for the subsequent stages of the screening process.
The cellular health screening market report table of contents includes:
1. Executive Summary
2.Cellular Health Screening Market Characteristics
3.Cellular Health Screening Market Trends And Strategies
4.Cellular Health Screening Market
5.Cellular Health Screening Market Size And Growth
6.Cellular Health Screening Segmentation
7.Cellular Health Screening Regional And Country Analysis
.
.
.
27. Cellular Health ScreeningCompetitive Landscape And Company Profiles
28.Cellular Health Screening Key Mergers And Acquisitions
29.Cellular Health Screening Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Bio-Reference Laboratories Inc.
- Laboratory Corporation, Quest Diagnostics Incorporated
- Cell Science Systems
- Genova Diagnostics
- Bio-Reference Laboratories Inc.
- Laboratory Corporatiation
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
